These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Rasouli M; Kiasari AM; Mokhberi V Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071 [TBL] [Abstract][Full Text] [Related]
4. Body iron stores and coronary atherosclerosis assessed by coronary angiography. Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):285-90. PubMed ID: 12616808 [TBL] [Abstract][Full Text] [Related]
5. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries]. Bukowska H Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530 [TBL] [Abstract][Full Text] [Related]
6. [The relationship between hyperfibrinogenemia and severity of coronary heart disease]. Liu MY; Hu DY; Yan L; Liu WH; Liu RH Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):820-3. PubMed ID: 15634539 [TBL] [Abstract][Full Text] [Related]
7. [Lipid indicators of vascular risk. A cross-sectional study of a group of coronary patients, a group of subjects with normal coronary angiography and a control group]. Heim M; Bory M; Ardissone JP; De Rocca Serra M; Giordanella JP; Auquier P; Juhan-Vague I; Simonin R Ann Cardiol Angeiol (Paris); 1992 Feb; 41(2):87-91. PubMed ID: 1562163 [TBL] [Abstract][Full Text] [Related]
8. Association of plasma fatty acid alteration with the severity of coronary artery disease lesions in Tunisian patients. Hadj Ahmed S; Kaoubaa N; Kharroubi W; Zarrouk A; Najjar MF; Batbout F; Gamra H; Lizard G; Hammami M Lipids Health Dis; 2017 Aug; 16(1):154. PubMed ID: 28806974 [TBL] [Abstract][Full Text] [Related]
9. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. Natarajan P; Collier TS; Jin Z; Lyass A; Li Y; Ibrahim NE; Mukai R; McCarthy CP; Massaro JM; D'Agostino RB; Gaggin HK; Bystrom C; Penn MS; Januzzi JL J Am Coll Cardiol; 2019 May; 73(17):2135-2145. PubMed ID: 31047001 [TBL] [Abstract][Full Text] [Related]
10. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296 [TBL] [Abstract][Full Text] [Related]
11. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Tkác I; Kimball BP; Lewis G; Uffelman K; Steiner G Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3633-8. PubMed ID: 9437215 [TBL] [Abstract][Full Text] [Related]
12. [The association between uric acid and coronary heart disease]. Lu P; Hu D; Lu J; Wang W; Chen B Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):526-9. PubMed ID: 12421499 [TBL] [Abstract][Full Text] [Related]
13. Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipoprotein risk factors for coronary artery disease in children. Ohta T; Saku K; Takata K; Adachi N Eur J Pediatr; 1999 Jul; 158(7):592-8. PubMed ID: 10412822 [TBL] [Abstract][Full Text] [Related]
14. Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography. Kabakci G; Yildirir A; Can I; Unsal I; Erbas B Cardiology; 1999; 92(4):221-5. PubMed ID: 10844380 [TBL] [Abstract][Full Text] [Related]
15. [Lipid profile of subjects undergoing coronary angiography in different Brazilian regions]. Forti N; Fukushima J; Giannini SD Arq Bras Cardiol; 1997 May; 68(5):333-42. PubMed ID: 9497521 [TBL] [Abstract][Full Text] [Related]
16. [Study of the changes in protein-lipid components of blood lipoproteins and the dynamics of coronary arteriosclerosis based on repeated angiographic examination]. Nechaev AS; Gratsianskiĭ NA; Olfer'ev AM; Metel'skaia VA; Mazaev VP Kardiologiia; 1989 Apr; 29(4):16-21. PubMed ID: 2754908 [No Abstract] [Full Text] [Related]
17. [Correlation between cardiovascular risk factors and the severity of coronary artery lesions in female patients]. Hu W; Guo ZG; Chen J; Zhou ZJ Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):307-9. PubMed ID: 19246308 [TBL] [Abstract][Full Text] [Related]
18. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction. Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220 [TBL] [Abstract][Full Text] [Related]
19. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913 [TBL] [Abstract][Full Text] [Related]
20. HDL-cholesterol concentration and severity of coronary atherosclerosis determined by cine-angiography. Naito HK; Greenstreet RL; David JA; Sheldon WL; Shirey EK; Lewis RC; Proudfit WL; Gerrity RG Artery; 1980; 8(2):101-12. PubMed ID: 7458675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]